JAK2 and hepatocellular carcinoma: As with the α7-nAChR, we demonstrated JAK2 immunopositivity in patients with HCC who were also current smokers, compared to very mild JAK2 immunopositivity in persons without HCC and who were non-smokers (Figure 4D).